Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India
open access
Keywords
Acute lymphoblastic leukemia (ALL)
Pegaspargase (PEG-ASP)
Hypersensitivity
Safety
Cited by (0)
Peer review under responsibility of Pediatric Hematology Oncology Chapter of Indian Academy of Pediatrics.
© 2018 Pediatric Hematology Oncology Chapter of Indian Academy of Pediatrics. Publishing Services by Elsevier B.V. All rights reserved.